| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Cardiorespiratory Fitness | 20 | 2021 | 313 | 6.13 | Why? |
| Healthy Lifestyle | 15 | 2021 | 447 | 5.54 | Why? |
| Exercise Test | 30 | 2021 | 911 | 3.42 | Why? |
| Cardiac Rehabilitation | 15 | 2021 | 525 | 3.00 | Why? |
| Exercise | 38 | 2021 | 6771 | 2.90 | Why? |
| Risk Reduction Behavior | 8 | 2021 | 946 | 2.57 | Why? |
| Exercise Tolerance | 18 | 2021 | 634 | 2.18 | Why? |
| Oxygen Consumption | 20 | 2018 | 711 | 2.07 | Why? |
| Exercise Therapy | 15 | 2020 | 976 | 1.90 | Why? |
| Health Promotion | 11 | 2018 | 2020 | 1.88 | Why? |
| Precision Medicine | 5 | 2018 | 1477 | 1.79 | Why? |
| Patient-Centered Care | 4 | 2018 | 860 | 1.62 | Why? |
| Physical Fitness | 8 | 2021 | 334 | 1.46 | Why? |
| Heart Failure | 17 | 2018 | 6638 | 1.16 | Why? |
| Cardiovascular Diseases | 18 | 2021 | 11497 | 1.16 | Why? |
| Preventive Medicine | 3 | 2017 | 242 | 1.15 | Why? |
| Chronic Disease | 6 | 2021 | 5139 | 1.10 | Why? |
| Weight Loss | 8 | 2019 | 826 | 0.99 | Why? |
| Physical Therapists | 2 | 2017 | 311 | 0.95 | Why? |
| Posture | 2 | 2020 | 199 | 0.90 | Why? |
| Life Style | 7 | 2021 | 2708 | 0.88 | Why? |
| Protective Factors | 8 | 2020 | 1720 | 0.83 | Why? |
| Stroke Volume | 10 | 2018 | 2153 | 0.82 | Why? |
| Movement | 1 | 2020 | 232 | 0.73 | Why? |
| Immunity | 2 | 2020 | 2651 | 0.73 | Why? |
| Carbon Dioxide | 3 | 2017 | 917 | 0.72 | Why? |
| Body Composition | 4 | 2021 | 414 | 0.72 | Why? |
| Adrenocorticotropic Hormone | 1 | 2017 | 107 | 0.68 | Why? |
| Coronary Artery Disease | 5 | 2019 | 2570 | 0.67 | Why? |
| Diet | 5 | 2018 | 2052 | 0.67 | Why? |
| Obesity | 9 | 2021 | 7388 | 0.64 | Why? |
| Adiposity | 1 | 2019 | 329 | 0.63 | Why? |
| Rehabilitation Centers | 1 | 2019 | 252 | 0.63 | Why? |
| Physical Therapy Specialty | 1 | 2017 | 69 | 0.61 | Why? |
| Mentors | 1 | 2019 | 372 | 0.60 | Why? |
| Education, Graduate | 1 | 2017 | 118 | 0.59 | Why? |
| Education, Professional | 1 | 2017 | 128 | 0.57 | Why? |
| Hypertension, Pulmonary | 3 | 2018 | 970 | 0.56 | Why? |
| Community-Based Participatory Research | 1 | 2017 | 271 | 0.55 | Why? |
| School Health Services | 1 | 2018 | 294 | 0.54 | Why? |
| Interleukin-1 | 4 | 2018 | 438 | 0.53 | Why? |
| Models, Educational | 1 | 2017 | 289 | 0.53 | Why? |
| Cardiovascular System | 2 | 2020 | 750 | 0.53 | Why? |
| Respiratory Muscles | 4 | 2020 | 116 | 0.53 | Why? |
| Coronary Stenosis | 1 | 2017 | 273 | 0.52 | Why? |
| Motor Activity | 1 | 2014 | 217 | 0.49 | Why? |
| Inservice Training | 1 | 2017 | 477 | 0.48 | Why? |
| Activities of Daily Living | 2 | 2021 | 1530 | 0.48 | Why? |
| Physical Therapy Modalities | 2 | 2017 | 1090 | 0.45 | Why? |
| Health Behavior | 7 | 2019 | 4449 | 0.44 | Why? |
| Ambulatory Care | 2 | 2019 | 4947 | 0.44 | Why? |
| Virtual Reality | 1 | 2019 | 640 | 0.43 | Why? |
| Natriuretic Peptide, Brain | 1 | 2017 | 1215 | 0.41 | Why? |
| Health Education | 1 | 2021 | 1539 | 0.39 | Why? |
| Ventricular Function, Left | 5 | 2018 | 1555 | 0.39 | Why? |
| Interleukin 1 Receptor Antagonist Protein | 4 | 2018 | 1165 | 0.39 | Why? |
| Humans | 115 | 2021 | 930598 | 0.38 | Why? |
| Heart Defects, Congenital | 1 | 2018 | 933 | 0.38 | Why? |
| Walk Test | 4 | 2018 | 461 | 0.36 | Why? |
| Muscle, Skeletal | 4 | 2021 | 915 | 0.36 | Why? |
| Referral and Consultation | 4 | 2019 | 4816 | 0.36 | Why? |
| Heart Failure, Systolic | 2 | 2018 | 39 | 0.35 | Why? |
| Coronary Artery Bypass | 3 | 2019 | 629 | 0.35 | Why? |
| Diabetes Mellitus, Type 2 | 5 | 2021 | 6166 | 0.34 | Why? |
| Breathing Exercises | 2 | 2020 | 118 | 0.34 | Why? |
| Health Status | 7 | 2018 | 3259 | 0.33 | Why? |
| Hydrocortisone | 1 | 2017 | 1790 | 0.33 | Why? |
| Delivery of Health Care, Integrated | 1 | 2018 | 1549 | 0.33 | Why? |
| Risk Factors | 22 | 2021 | 71621 | 0.32 | Why? |
| Health Literacy | 1 | 2017 | 1078 | 0.32 | Why? |
| Peptide Fragments | 1 | 2017 | 2075 | 0.32 | Why? |
| Electric Stimulation Therapy | 2 | 2018 | 151 | 0.30 | Why? |
| Oxygen | 4 | 2018 | 3715 | 0.29 | Why? |
| Information Dissemination | 1 | 2021 | 2986 | 0.28 | Why? |
| Patient Education as Topic | 3 | 2021 | 1476 | 0.28 | Why? |
| Cardiotonic Agents | 2 | 2018 | 418 | 0.28 | Why? |
| Cardiology | 1 | 2019 | 2873 | 0.27 | Why? |
| Cardiac Output, Low | 1 | 2003 | 31 | 0.27 | Why? |
| Public Health | 2 | 2020 | 16359 | 0.26 | Why? |
| Delivery of Health Care | 3 | 2020 | 15909 | 0.25 | Why? |
| Heart Rate | 5 | 2018 | 1527 | 0.25 | Why? |
| Disease Management | 3 | 2018 | 6841 | 0.25 | Why? |
| Walking | 2 | 2018 | 442 | 0.24 | Why? |
| Ventricular Dysfunction, Left | 4 | 2018 | 993 | 0.24 | Why? |
| Muscle Strength | 4 | 2018 | 317 | 0.24 | Why? |
| Predictive Value of Tests | 7 | 2018 | 9537 | 0.24 | Why? |
| Time Factors | 13 | 2018 | 31397 | 0.24 | Why? |
| Vascular Resistance | 2 | 2017 | 148 | 0.23 | Why? |
| Body Mass Index | 4 | 2018 | 4306 | 0.23 | Why? |
| Blood Pressure | 6 | 2018 | 2198 | 0.23 | Why? |
| Sex Factors | 3 | 2019 | 11014 | 0.23 | Why? |
| Universities | 1 | 2017 | 4374 | 0.23 | Why? |
| Alberta | 2 | 2019 | 375 | 0.22 | Why? |
| Health Policy | 2 | 2021 | 6242 | 0.22 | Why? |
| Pulmonary Gas Exchange | 3 | 2018 | 414 | 0.22 | Why? |
| Telerehabilitation | 2 | 2020 | 736 | 0.22 | Why? |
| Program Development | 2 | 2018 | 1089 | 0.22 | Why? |
| Musculoskeletal Physiological Phenomena | 1 | 2020 | 10 | 0.22 | Why? |
| Brachial Artery | 1 | 2021 | 107 | 0.21 | Why? |
| Muscles | 1 | 2021 | 152 | 0.21 | Why? |
| Regional Blood Flow | 1 | 2021 | 172 | 0.21 | Why? |
| Acute Coronary Syndrome | 3 | 2018 | 2107 | 0.21 | Why? |
| Biomedical Research | 1 | 2021 | 5270 | 0.21 | Why? |
| Pulmonary Ventilation | 2 | 2018 | 152 | 0.20 | Why? |
| Social Isolation | 1 | 2020 | 5932 | 0.20 | Why? |
| Patient Compliance | 3 | 2018 | 1468 | 0.20 | Why? |
| Forced Expiratory Volume | 3 | 2018 | 632 | 0.20 | Why? |
| Isometric Contraction | 1 | 2019 | 19 | 0.20 | Why? |
| Pandemics | 14 | 2021 | 389249 | 0.20 | Why? |
| Physical Exertion | 3 | 2018 | 176 | 0.19 | Why? |
| Adolescent Nutritional Physiological Phenomena | 1 | 2018 | 13 | 0.19 | Why? |
| Intention | 2 | 2018 | 1380 | 0.19 | Why? |
| Dietary Approaches To Stop Hypertension | 1 | 2018 | 8 | 0.19 | Why? |
| Prognosis | 12 | 2018 | 32490 | 0.19 | Why? |
| Ventricular Dysfunction | 2 | 2018 | 150 | 0.19 | Why? |
| Resistance Training | 2 | 2018 | 273 | 0.19 | Why? |
| Child Nutritional Physiological Phenomena | 1 | 2018 | 40 | 0.19 | Why? |
| Vasodilation | 1 | 2021 | 258 | 0.19 | Why? |
| Communication | 1 | 2017 | 5206 | 0.19 | Why? |
| Anthropometry | 1 | 2019 | 233 | 0.18 | Why? |
| Coronary Artery Bypass, Off-Pump | 1 | 2018 | 27 | 0.18 | Why? |
| Reference Values | 2 | 2018 | 795 | 0.18 | Why? |
| Health Knowledge, Attitudes, Practice | 5 | 2018 | 8811 | 0.18 | Why? |
| Muscle Contraction | 1 | 2018 | 60 | 0.18 | Why? |
| Motivational Interviewing | 1 | 2018 | 55 | 0.18 | Why? |
| Motivation | 2 | 2018 | 1640 | 0.18 | Why? |
| Fitness Trackers | 1 | 2018 | 120 | 0.17 | Why? |
| Eisenmenger Complex | 1 | 2017 | 16 | 0.17 | Why? |
| Hypertension | 5 | 2018 | 8895 | 0.17 | Why? |
| Coronary Angiography | 2 | 2017 | 2275 | 0.17 | Why? |
| Internship, Nonmedical | 1 | 2017 | 30 | 0.17 | Why? |
| Clinical Trials as Topic | 1 | 2017 | 7330 | 0.17 | Why? |
| Echocardiography, Stress | 1 | 2017 | 65 | 0.17 | Why? |
| Cardiovascular Physiological Phenomena | 1 | 2017 | 70 | 0.17 | Why? |
| Inspiratory Capacity | 1 | 2016 | 47 | 0.16 | Why? |
| Quality of Life | 8 | 2021 | 9820 | 0.16 | Why? |
| Spinal Cord Injuries | 1 | 2021 | 270 | 0.16 | Why? |
| Primary Prevention | 2 | 2021 | 778 | 0.16 | Why? |
| Registries | 6 | 2018 | 12327 | 0.16 | Why? |
| Follow-Up Studies | 10 | 2021 | 17020 | 0.16 | Why? |
| Recovery of Function | 5 | 2018 | 2461 | 0.16 | Why? |
| Rest | 1 | 2017 | 188 | 0.16 | Why? |
| Autonomic Nervous System | 1 | 2018 | 148 | 0.16 | Why? |
| Weight Reduction Programs | 1 | 2017 | 87 | 0.16 | Why? |
| Infrared Rays | 1 | 2017 | 127 | 0.16 | Why? |
| Bicycling | 1 | 2018 | 133 | 0.16 | Why? |
| Diabetic Angiopathies | 1 | 2018 | 146 | 0.16 | Why? |
| Heart Transplantation | 2 | 2017 | 1293 | 0.15 | Why? |
| Female | 44 | 2021 | 380317 | 0.15 | Why? |
| Physical Endurance | 1 | 2016 | 107 | 0.15 | Why? |
| Connective Tissue Diseases | 1 | 2018 | 187 | 0.15 | Why? |
| Severity of Illness Index | 6 | 2018 | 48226 | 0.15 | Why? |
| Fasting | 1 | 2021 | 555 | 0.15 | Why? |
| Benzhydryl Compounds | 1 | 2018 | 240 | 0.15 | Why? |
| Echocardiography, Doppler | 4 | 2018 | 269 | 0.15 | Why? |
| Postmenopause | 1 | 2017 | 160 | 0.15 | Why? |
| Male | 43 | 2021 | 367725 | 0.15 | Why? |
| Phototherapy | 1 | 2017 | 138 | 0.15 | Why? |
| Influenza, Human | 1 | 2020 | 10779 | 0.14 | Why? |
| Smoking Cessation | 2 | 2021 | 826 | 0.14 | Why? |
| Stroke | 1 | 2018 | 8839 | 0.14 | Why? |
| Life Expectancy | 1 | 2020 | 474 | 0.14 | Why? |
| Child Behavior | 1 | 2018 | 266 | 0.14 | Why? |
| Lactic Acid | 4 | 2018 | 393 | 0.14 | Why? |
| Noninvasive Ventilation | 2 | 2018 | 2329 | 0.14 | Why? |
| Lipids | 2 | 2018 | 1079 | 0.14 | Why? |
| Hemodynamics | 2 | 2020 | 1562 | 0.14 | Why? |
| Ventricular Remodeling | 1 | 2018 | 349 | 0.14 | Why? |
| Islam | 1 | 2021 | 545 | 0.14 | Why? |
| Cardiac Resynchronization Therapy | 1 | 2017 | 191 | 0.14 | Why? |
| Analysis of Variance | 3 | 2018 | 950 | 0.14 | Why? |
| Diastole | 1 | 2014 | 168 | 0.14 | Why? |
| Asia | 2 | 2018 | 2399 | 0.14 | Why? |
| Chicago | 1 | 2017 | 653 | 0.14 | Why? |
| Glucosides | 1 | 2018 | 359 | 0.14 | Why? |
| Meningoencephalitis | 1 | 2017 | 208 | 0.13 | Why? |
| Middle Aged | 36 | 2021 | 270681 | 0.13 | Why? |
| Models, Organizational | 1 | 2020 | 908 | 0.13 | Why? |
| Treatment Outcome | 15 | 2018 | 51732 | 0.13 | Why? |
| Postoperative Care | 1 | 2019 | 755 | 0.13 | Why? |
| Professional Competence | 1 | 2017 | 246 | 0.13 | Why? |
| Ventricular Function, Right | 1 | 2017 | 388 | 0.13 | Why? |
| Anaerobic Threshold | 1 | 2013 | 42 | 0.13 | Why? |
| Soccer | 1 | 2017 | 259 | 0.12 | Why? |
| Adolescent Behavior | 1 | 2018 | 400 | 0.12 | Why? |
| Mitral Valve Insufficiency | 1 | 2017 | 302 | 0.12 | Why? |
| Body Weight | 1 | 2018 | 1074 | 0.12 | Why? |
| Metabolome | 1 | 2017 | 624 | 0.12 | Why? |
| Aged | 27 | 2019 | 215776 | 0.12 | Why? |
| Professional-Patient Relations | 1 | 2017 | 426 | 0.11 | Why? |
| Coronary Disease | 1 | 2018 | 645 | 0.11 | Why? |
| Phenotype | 3 | 2018 | 4037 | 0.11 | Why? |
| Nutritional Status | 2 | 2020 | 1403 | 0.11 | Why? |
| Risk Assessment | 5 | 2020 | 25439 | 0.11 | Why? |
| Pediatric Obesity | 1 | 2017 | 492 | 0.11 | Why? |
| Heart Ventricles | 2 | 2017 | 1139 | 0.11 | Why? |
| Echocardiography | 4 | 2018 | 3661 | 0.11 | Why? |
| Bariatric Surgery | 2 | 2018 | 1298 | 0.11 | Why? |
| Program Evaluation | 1 | 2019 | 1929 | 0.11 | Why? |
| Cardiovascular Agents | 1 | 2017 | 663 | 0.11 | Why? |
| Noncommunicable Diseases | 1 | 2020 | 934 | 0.11 | Why? |
| Malnutrition | 1 | 2020 | 932 | 0.11 | Why? |
| Models, Biological | 2 | 2018 | 4907 | 0.11 | Why? |
| Disabled Persons | 1 | 2021 | 1152 | 0.10 | Why? |
| Needs Assessment | 1 | 2020 | 2352 | 0.10 | Why? |
| Reference Standards | 3 | 2019 | 1163 | 0.10 | Why? |
| Pulmonary Artery | 1 | 2017 | 803 | 0.10 | Why? |
| Endothelium, Vascular | 1 | 2021 | 1751 | 0.10 | Why? |
| Positive-Pressure Respiration | 1 | 2018 | 1160 | 0.10 | Why? |
| Adaptation, Physiological | 1 | 2013 | 359 | 0.10 | Why? |
| Muscle Fatigue | 2 | 2019 | 25 | 0.10 | Why? |
| Asthma | 2 | 2019 | 4383 | 0.10 | Why? |
| Survival Rate | 4 | 2019 | 9206 | 0.09 | Why? |
| Kinetics | 1 | 2017 | 3238 | 0.09 | Why? |
| Adult | 23 | 2021 | 244371 | 0.09 | Why? |
| Databases, Factual | 3 | 2018 | 6248 | 0.09 | Why? |
| Fellowships and Scholarships | 1 | 2017 | 931 | 0.09 | Why? |
| Prospective Studies | 9 | 2021 | 43301 | 0.09 | Why? |
| Anti-Inflammatory Agents | 2 | 2017 | 6153 | 0.09 | Why? |
| Blood Glucose | 2 | 2018 | 3642 | 0.08 | Why? |
| Guidelines as Topic | 1 | 2020 | 2844 | 0.08 | Why? |
| Virginia | 2 | 2017 | 228 | 0.08 | Why? |
| Health Personnel | 1 | 2017 | 29646 | 0.08 | Why? |
| Double-Blind Method | 4 | 2018 | 5988 | 0.08 | Why? |
| Vital Capacity | 2 | 2018 | 399 | 0.08 | Why? |
| Obesity, Morbid | 1 | 2017 | 1340 | 0.08 | Why? |
| Inflammation Mediators | 1 | 2017 | 2654 | 0.08 | Why? |
| Influenza A Virus, H1N1 Subtype | 1 | 2020 | 2984 | 0.07 | Why? |
| Postoperative Complications | 3 | 2018 | 5861 | 0.07 | Why? |
| Aorta, Thoracic | 1 | 2007 | 271 | 0.07 | Why? |
| Biomarkers | 5 | 2018 | 23361 | 0.07 | Why? |
| Global Health | 2 | 2020 | 13911 | 0.07 | Why? |
| C-Reactive Protein | 2 | 2018 | 7972 | 0.07 | Why? |
| Sleep Initiation and Maintenance Disorders | 1 | 2017 | 1692 | 0.07 | Why? |
| Spirometry | 2 | 2018 | 524 | 0.07 | Why? |
| Lung Diseases | 1 | 2018 | 2361 | 0.07 | Why? |
| Zika Virus | 1 | 2017 | 1924 | 0.07 | Why? |
| Workplace | 1 | 2016 | 2075 | 0.07 | Why? |
| Hospitalization | 4 | 2021 | 54280 | 0.07 | Why? |
| Research | 1 | 2017 | 2115 | 0.07 | Why? |
| Curriculum | 1 | 2017 | 3083 | 0.06 | Why? |
| Zika Virus Infection | 1 | 2017 | 1920 | 0.06 | Why? |
| Oxygen Inhalation Therapy | 1 | 2017 | 3629 | 0.06 | Why? |
| Mobile Applications | 1 | 2018 | 3032 | 0.06 | Why? |
| Decision Making | 1 | 2017 | 3132 | 0.06 | Why? |
| Aging | 1 | 2018 | 3581 | 0.06 | Why? |
| Health Services Needs and Demand | 1 | 2017 | 3419 | 0.06 | Why? |
| ST Elevation Myocardial Infarction | 1 | 2018 | 3051 | 0.06 | Why? |
| ROC Curve | 2 | 2004 | 6024 | 0.05 | Why? |
| Pulmonary Disease, Chronic Obstructive | 1 | 2018 | 3832 | 0.05 | Why? |
| Myocardial Infarction | 1 | 2016 | 3361 | 0.05 | Why? |
| Immunocompromised Host | 1 | 2017 | 5150 | 0.05 | Why? |
| Pneumonia, Viral | 4 | 2020 | 243684 | 0.05 | Why? |
| Patient Acceptance of Health Care | 1 | 2018 | 5002 | 0.05 | Why? |
| Coronavirus Infections | 4 | 2020 | 253789 | 0.05 | Why? |
| Host-Pathogen Interactions | 1 | 2020 | 11041 | 0.05 | Why? |
| Platelet Adhesiveness | 1 | 2018 | 19 | 0.05 | Why? |
| Evidence-Based Medicine | 1 | 2013 | 3228 | 0.05 | Why? |
| Potassium, Dietary | 1 | 2018 | 10 | 0.05 | Why? |
| Quadriceps Muscle | 1 | 2019 | 50 | 0.05 | Why? |
| Anti-Obesity Agents | 1 | 2018 | 52 | 0.05 | Why? |
| Sodium, Dietary | 1 | 2018 | 45 | 0.05 | Why? |
| Immunosuppressive Agents | 1 | 2017 | 6331 | 0.04 | Why? |
| New Orleans | 1 | 2018 | 166 | 0.04 | Why? |
| Skinfold Thickness | 1 | 2017 | 13 | 0.04 | Why? |
| Sterilization | 1 | 2021 | 294 | 0.04 | Why? |
| Adolescent | 5 | 2018 | 86841 | 0.04 | Why? |
| Sri Lanka | 1 | 2018 | 241 | 0.04 | Why? |
| Body Weights and Measures | 1 | 2017 | 50 | 0.04 | Why? |
| Plasminogen Activator Inhibitor 1 | 1 | 2018 | 162 | 0.04 | Why? |
| Ergometry | 1 | 2016 | 6 | 0.04 | Why? |
| Parenchymal Tissue | 1 | 2017 | 61 | 0.04 | Why? |
| Waist Circumference | 1 | 2017 | 199 | 0.04 | Why? |
| Low-Level Light Therapy | 1 | 2019 | 129 | 0.04 | Why? |
| Stress, Psychological | 1 | 2020 | 10231 | 0.04 | Why? |
| Food Assistance | 1 | 2020 | 250 | 0.04 | Why? |
| Platelet Aggregation | 1 | 2018 | 318 | 0.04 | Why? |
| Spectroscopy, Near-Infrared | 1 | 2017 | 137 | 0.04 | Why? |
| Sample Size | 1 | 2018 | 518 | 0.04 | Why? |
| Postoperative Period | 1 | 2018 | 651 | 0.04 | Why? |
| Organizational Policy | 1 | 2021 | 694 | 0.04 | Why? |
| Cerebrospinal Fluid | 1 | 2017 | 234 | 0.04 | Why? |
| Rehabilitation | 1 | 2021 | 386 | 0.04 | Why? |
| Social Environment | 1 | 2018 | 389 | 0.04 | Why? |
| Arterial Pressure | 1 | 2017 | 208 | 0.04 | Why? |
| Running | 1 | 2017 | 153 | 0.04 | Why? |
| American Heart Association | 1 | 2017 | 347 | 0.04 | Why? |
| Pilot Projects | 2 | 2017 | 5182 | 0.04 | Why? |
| Statistics, Nonparametric | 1 | 2018 | 1008 | 0.03 | Why? |
| Outpatients | 2 | 2018 | 3417 | 0.03 | Why? |
| Prevalence | 1 | 2017 | 25773 | 0.03 | Why? |
| Blood Gas Analysis | 1 | 2018 | 893 | 0.03 | Why? |
| United States | 5 | 2021 | 46150 | 0.03 | Why? |
| Anxiety | 1 | 2020 | 17311 | 0.03 | Why? |
| Data Interpretation, Statistical | 1 | 2018 | 657 | 0.03 | Why? |
| Retrospective Studies | 7 | 2019 | 105322 | 0.03 | Why? |
| Fluorescent Antibody Technique | 1 | 2017 | 835 | 0.03 | Why? |
| Blood Pressure Determination | 1 | 2017 | 450 | 0.03 | Why? |
| Cross-Over Studies | 1 | 2017 | 867 | 0.03 | Why? |
| Diet, Mediterranean | 1 | 2018 | 351 | 0.03 | Why? |
| Respiratory Therapy | 1 | 2020 | 918 | 0.03 | Why? |
| Secondary Prevention | 1 | 2018 | 762 | 0.03 | Why? |
| Quarantine | 1 | 2020 | 18418 | 0.03 | Why? |
| Age Factors | 3 | 2019 | 21039 | 0.03 | Why? |
| Respiratory Tract Diseases | 1 | 2021 | 1061 | 0.03 | Why? |
| Disease-Free Survival | 1 | 2017 | 1654 | 0.03 | Why? |
| Bangladesh | 1 | 2018 | 1620 | 0.03 | Why? |
| Overweight | 1 | 2018 | 916 | 0.03 | Why? |
| Risk Management | 1 | 2020 | 1044 | 0.03 | Why? |
| Self Efficacy | 1 | 2018 | 717 | 0.03 | Why? |
| Morbidity | 1 | 2018 | 1426 | 0.03 | Why? |
| Child | 2 | 2018 | 70012 | 0.03 | Why? |
| Healthy Volunteers | 1 | 2017 | 1444 | 0.03 | Why? |
| Hemoglobins | 1 | 2017 | 958 | 0.03 | Why? |
| Proportional Hazards Models | 1 | 2004 | 6543 | 0.03 | Why? |
| Reproducibility of Results | 2 | 2018 | 11304 | 0.03 | Why? |
| Regression Analysis | 1 | 2018 | 2484 | 0.03 | Why? |
| Infection Control | 1 | 2020 | 23131 | 0.03 | Why? |
| Communicable Disease Control | 1 | 2020 | 29620 | 0.03 | Why? |
| Cardiac Catheterization | 1 | 2018 | 882 | 0.03 | Why? |
| Drug Administration Schedule | 1 | 2017 | 2324 | 0.03 | Why? |
| Respiratory Function Tests | 1 | 2018 | 1755 | 0.03 | Why? |
| Pakistan | 1 | 2018 | 2302 | 0.03 | Why? |
| Aged, 80 and over | 5 | 2018 | 88759 | 0.03 | Why? |
| Young Adult | 5 | 2018 | 93724 | 0.03 | Why? |
| Survival Analysis | 1 | 2004 | 7592 | 0.03 | Why? |
| Sleep Apnea, Obstructive | 1 | 2018 | 668 | 0.03 | Why? |
| Length of Stay | 2 | 2018 | 11042 | 0.03 | Why? |
| Cross-Sectional Studies | 4 | 2018 | 53120 | 0.03 | Why? |
| Brazil | 2 | 2018 | 12582 | 0.03 | Why? |
| Organizational Innovation | 1 | 2020 | 2468 | 0.02 | Why? |
| Electrocardiography | 2 | 2018 | 3957 | 0.02 | Why? |
| Neuroimaging | 1 | 2017 | 1106 | 0.02 | Why? |
| Immunohistochemistry | 1 | 2017 | 2275 | 0.02 | Why? |
| Randomized Controlled Trials as Topic | 2 | 2018 | 10649 | 0.02 | Why? |
| Dose-Response Relationship, Drug | 1 | 2018 | 3776 | 0.02 | Why? |
| Iran | 1 | 2021 | 5467 | 0.02 | Why? |
| Myocardium | 1 | 2020 | 2323 | 0.02 | Why? |
| Combined Modality Therapy | 1 | 2017 | 3395 | 0.02 | Why? |
| Feeding Behavior | 1 | 2020 | 1909 | 0.02 | Why? |
| Fatal Outcome | 1 | 2017 | 3438 | 0.02 | Why? |
| Heart | 1 | 2017 | 1791 | 0.02 | Why? |
| Patient Isolation | 1 | 2020 | 3182 | 0.02 | Why? |
| Comorbidity | 2 | 2021 | 34796 | 0.02 | Why? |
| Patient Care Management | 1 | 2018 | 1514 | 0.02 | Why? |
| Magnetic Resonance Imaging | 2 | 2017 | 6551 | 0.02 | Why? |
| Clinical Protocols | 1 | 2017 | 2734 | 0.02 | Why? |
| Respiration, Artificial | 2 | 2020 | 22116 | 0.02 | Why? |
| Patient Discharge | 1 | 2021 | 5696 | 0.02 | Why? |
| Social Support | 1 | 2018 | 3183 | 0.02 | Why? |
| Betacoronavirus | 4 | 2020 | 204454 | 0.02 | Why? |
| Acute Disease | 1 | 2017 | 6029 | 0.02 | Why? |
| Genetic Predisposition to Disease | 1 | 2018 | 4027 | 0.02 | Why? |
| Antirheumatic Agents | 1 | 2018 | 3023 | 0.02 | Why? |
| Immunity, Innate | 1 | 2021 | 6570 | 0.02 | Why? |
| Signal Transduction | 1 | 2018 | 7207 | 0.01 | Why? |
| India | 1 | 2018 | 11875 | 0.01 | Why? |
| Research Design | 1 | 2017 | 5830 | 0.01 | Why? |
| Surveys and Questionnaires | 2 | 2018 | 43792 | 0.01 | Why? |
| Diagnosis, Differential | 1 | 2014 | 7220 | 0.01 | Why? |
| Disease Progression | 1 | 2018 | 13580 | 0.01 | Why? |
| Case-Control Studies | 1 | 2016 | 17671 | 0.01 | Why? |
| Disease Transmission, Infectious | 1 | 2020 | 9044 | 0.01 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2017 | 13720 | 0.01 | Why? |
| Practice Guidelines as Topic | 1 | 2021 | 15421 | 0.01 | Why? |
| Cytokines | 1 | 2018 | 15010 | 0.01 | Why? |
| Genome, Viral | 1 | 2017 | 13157 | 0.01 | Why? |
| Cohort Studies | 1 | 2018 | 36005 | 0.01 | Why? |
| Telemedicine | 1 | 2021 | 25032 | 0.01 | Why? |